Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics

Apax Partners acquires Unilabs from Nordic Capital and Apax Partners France

MDBR Staff Writer Published 13 December 2016

Apax Partners has acquired Switzerland-based medical diagnostic provider Unilabs from Nordic Capital and Apax Partners France.

Apax Partners invested through its Apax IX vehicle, for purchasing the stake from Nordic Capital Fund VI and Apax France VII, a vehicle managed by Apax Partners France.

Based in Geneva, Unilabs provides clinical laboratory testing and medical diagnostic imaging services.

Terms of the deal have not been disclosed.

The company operates around 112 laboratories and 43 imaging units across 10 European countries, as well as offers services in the Middle East and Latin America.

With a catalogue of more than 2,500 diagnostic tests, Unilabs services sectors range from private and public healthcare providers to local governments, pharmaceutical companies and the general public.

The group, which has around 5,300 employees, generated annual revenues of about €673m in 2015.

Unilabs CEO Jos Lamers said: “I would like to thank our partners for sharing our vision and for their support in building a company with solid market leadership positions.

“Today’s transaction will allow us to pursue our ambition to become a proactive partner to caregivers and patients in all areas of diagnostics – from laboratory diagnostics to pathology and medical imaging.”’

Apax Partners partner Steven Dyson said: “Under the leadership of CEO Jos Lamers and his executive team, Unilabs and its 5,300 employees have done an outstanding job in growing organic revenues at close to double market rates, and they continue to generate expanding operating margins.”


Image: Apax Partners acquires remaining stake in Unilabs. Photo: courtesy of PinkBlue / FreeDigitalPhotos.net.